Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients

Table 4 Correlation between inflammatory bowel disease perceived stigma scale scores and demographic or clinical characteristics

	PSS	P	Spearman’s correlation (95%CI)	PSS SO	P	Spearman’s correlation (95%CI)	PSS HP	P	Spearman’s correlation (95%CI)
Median score (IQR)	0.45 (0.20 to 0.85)			0.70 (0.30 to 1.40)			0.10 (0.00 to 0.40)
Age		0.11	-0.14 (-0.31 to 0.03)		0.08	-0.157 (-0.33 to 0.02)		0.20	-0.116 (-0.29 to 0.06)
Sex		0.51			0.26			0.29
Female	0.45 (0.30 to 0.85)			0.70 (0.50 to 1.40)			0.10 (0.00 to 0.40)
Male	0.45 (0.15 to 0.90)			0.70 (0.20 to 1.40)			0.10 (0.00 to 0.50)
Diagnosis		0.33			0.35			0.34
CD	0.55 (0.25 to 0.95)			0.80 (0.40 to 1.40)			0.10 (0.00 to 0.50)
UC	0.45 (0.20 to 0.85)			0.70 (0.30 to 1.30)			0.10 (0.00 to 0.40)
HBI		0.91	0.05 (-0.22 to 0.30)		0.91	0.05 (-0.21 to 0.31)		0.70	0.11 (-0.16 to 0.36)
< 5	0.53 (0.25 to 0.80)			0.75 (0.50 to 1.30)			0.10 (0.00 to 0.50)
5-7	0.60 (0.10 to 1.15)			0.90 (0.20 to 1.60)			0.30 (0.00 to 0.50)
8-16	0.40 (0.10 to 1.40)			0.70 (0.20 to 1.80)			0.10 (0.00 to 0.80)
pMS		0.52	0.06 (-0.18 to 0.29)		0.44	0.03 (-0.21 to 0.26)		0.81	0.11 (-0.13 to 0.34)
< 2	0.40 (0.20 to 0.85)			0.60 (0.40 to 1.30)			0.10 (0.00 to 0.30)
2-4	0.45 (0.05 to 0.75)			0.60 (0.10 to 1.20)			0.20 (0.00 to 0.40)
5-7	0.75 (0.48 to 1.22)			1.40 (0.90 to 1.75)			0.15 (0.05 to 0.70)
> 7	0.35 (0.15 to 1.50)			0.70 (0.00 to 2.70)			0.10 (0.00 to 0.70
CD-RISC25	-	0.03	-0.20 (-0.36 to -0.02)	-	0.02	-0.20 (-0.36 to -0.03)	-	0.12	-0.14 (-0.31 to 0.04)

CD: Crohn’s disease; CD-RISC25: 25-item Connor-Davidson Resilience Scale; CI: Confidence interval; HBI: Harvey-Bradshaw Index; HP: Healthcare professionals; IQR: Interquartile range; pMS: Partial Mayo Score; SO: Significant others; UC: Ulcerative colitis.